FDA approves new non-opioid pain reliever
Journavx is the first new type of pain reliever approved by the FDA to hit the market in more than two decades. Emory University's Dr. Neil Winawer sat down with Alyse Eady to do a deep dive into the drug.
Journavx is the first new type of pain reliever approved by the FDA to hit the market in more than two decades. Emory University's Dr. Neil Winawer sat down with Alyse Eady to do a deep dive into the drug.